Status:
COMPLETED
The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm®, Before and After Sperm Preparation for Clinical Pregnancy in Cases of Unexplained Infertility Treated With Intra-uterine Insemination (First Cycle) and Ovulation Induction With Clomiphene Citrate.
Lead Sponsor:
University Hospital, Ghent
Conditions:
Unexplained Infertility
Eligibility:
All Genders
18-40 years
Brief Summary
Recent research has revealed that subtle abnormalities can be found in sperm samples that seem to be normal with conventional analysis techniques. The DNA in the sperm heads is sometimes fragmented an...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Unexplained infertility, i.e. female patients with ovulatory cycles and patent tubes; normal sperm analysis (WHO criteria).
- Patient agrees to have a first treatment cycle with intra-uterine insemination and ovulation-induction with clomiphene citrate.
Exclusion
Key Trial Info
Start Date :
April 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT02235103
Start Date
April 1 2014
End Date
March 1 2016
Last Update
March 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fertility Centre of the University Hospital
Ghent, East Flanders, Belgium, 9000